Skip to main content

Posts

Pearl River County, Mississippi leaders move toward banning kratom

 Pearl River County leaders voted unanimously last week for an ordinance banning the sale of kratom. Kratom comes from a tropical tree native to Southeast Asia and has been used as herbal medicine since at least the 19th century. It also has opioid properties and some stimulating effects .It’s commonly sold in smoke shops and convenience stores, like at Pomp and Bees in Poplarville. “I know that they’re trying to take it off the market, but I don’t think that they should,” Mary Labruzzo told WLOX. Labruzzo is a store employee and said only taking half the pill helps with her arthritis and sciatic nerve. “It just takes whatever pain that I have. It just mellows it out, and then it’s just, I feel good and I can move again,” she said. “Then I can come to work and perform my job the way it needs to be performed.” However, other community members, like county deputy clerk Lauren Goar, are pushing for it to be prohibited. “It’s affecting our communities just as much as any other drug or sub
Recent posts

New Jay Street business in Schenectady focuses on controversial product

Between opening a shop in the middle of a pandemic, and selling a controversial product, Tracey Hudson has her work cut out for her.  The Perth resident recently opened The Kratom Shop at 160 Jay St., selling mainly kratom, which comes from a plant called mitragyna speciosa grown in southeast Asia. According to Hudson, it helps users with everything from pain to energy management, and can even help people wean themselves off of addictive opiates.  Kratom certainly has its detractors: the federal Food and Drug Administration has warned people not to use it and the Drug Enforcement Administration has listed it as a drug of concern . Several states have made it illegal as well.  Yet, some users have said it’s saved their lives.  “If you told me four years ago that I would ever say plants before pills… I’ve never thought that until I actually experienced a plant that made major changes in my life,” Hudson said.  She began using kratom about four years ago when she was working as a sales

Opiate Alternative Kratom Spurs Investor Interest

 Investors in cannabis and psychedelic drugs often talk excitedly about their promise to take a slice of the $20 billion-plus market for opioids and fix a societal addiction crisis along the way. Now, an under-the-radar drug has joined them as a potential disruptor. It’s already drawing interest from Atai Life Sciences, a biopharma company known for putting psychedelic compounds into clinical trials. And a recent decision from the World Health Organization could help it gain further traction. The drug is called kratom, and it’s made from the ground leaves of a psychoactive plant native to Southeast Asia. Kratom is already a $1.3 billion industry in the U.S. with sales occurring online and in smoke shops, according to the American Kratom Association . It’s also among the most commonly seized substances in the world among drugs classified as “new” by the United Nations. Millions of people use it for pain relief, to alleviate the symptoms of opiate withdrawal or simply for recreation. U.S

United Nations Panel Rejects International Kratom Ban

Kratom advocates are cheering a new decision from the United Nations World Health Organization (WHO) not to recommend that the plant-derived substance be internationally banned following a scientific review. There were some concerns that WHO’s Executive Committee on Drug Dependency (ECDD) would take steps to either urge international control over kratom—which has been touted as a natural painkiller that works as a safer alternative to prescription opioids—or recommend a critical review that could have ultimately led to scheduling following another year-long inquiry. But in a report released last week, members of ECDD voted 11-1 to simply continue monitoring data on the health impacts of kratom over the next two to three years, rather than institute strict controls. Members found “insufficient evidence” that kratom warrants a more in-depth critical review at this point. While the decision was based on a scientific review of the risk of dependence, abuse potential and therapeutic applica